FDA Clears Stroke2prevent's A-View Balloon Catheter for TEE

 

May 30, 2017—Stroke2prevent, a medical device company based in Zwolle, The Netherlands, announced that it has received US Food and Drug Administration 510(k) clearance for the company's A-View balloon catheter to visualize the aortic arch with transesophageal echocardiography (TEE).

The company stated that the A-View is designed to resolve a blind spot of TEE that is caused by the interposition of the trachea. The device provides imaging of the entire aortic arch to detect atherosclerosis, diagnose aortic diseases, and monitor vascular flow. The device is currently available in Europe and will be marketed in the United States, pending arrangements for distribution and clinical support.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.